跳至主要内容
临床试验/NCT04208035
NCT04208035Unknown不适用

Hepatitis C Elimination in the Netherlands (CELINE) - A National Multicenter Cohort Study Retrieving Lost to Follow-up Chronic Hepatitis C Patients

Radboud University Medical Center1 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2018年9月17日最近更新:
适应症

试验速览

阶段
不适用
入组人数
250
试验地点
1
主要终点
Number of lost to follow-up (LTFU) patients successfully re-linked to care

研究概览

简要总结

The aim of CELINE is to retrieve and re-evaluate lost to follow-up chronic hepatitis C patients in the Netherlands.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Ever diagnosed with (possible) chronic HCV in the 15-year period prior to initiation of the study, defined as having had a positive anti-HCV or HCV RNA test
  • Lost to follow-up, defined as the lack of a scheduled outpatient care appointment after the last known positive HCV test result

排除标准

  • Younger than 18
  • Not residing in the Netherlands
  • Unknown current address
  • Severe comorbidity or short life expectancy that limits patients from benefiting from retrieval

结局指标

主要结局

Number of lost to follow-up (LTFU) patients successfully re-linked to care

时间窗: End of study, on average 2.5 years after initiation

次要结局

  • Time of being LTFU(End of study, on average 2.5 years after initiation)
  • Reasons for becoming LTFU(End of study, on average 2.5 years after initiation)
  • Liver fibrosis stage of retrieved patients(End of study, on average 2.5 years after initiation)
  • Total number of LTFU patients in the investigated time period(15 years prior to study initiation)
  • Case ascertainment rate(End of study, on average 2.5 years after initiation)
  • Awareness of HCV diagnosis among LTFU patients(End of study, on average 2.5 years after initiation)
  • Number of patients who never had an outpatient appointment with a hepatologist or infectious disease specialist after initial positive HCV test(End of study, on average 2.5 years after initiation)
  • Number of viraemic patients at time of re-evaluation(End of study, on average 2.5 years after initiation)
  • Mode of HCV transmission(End of study, on average 2.5 years after initiation)
  • Sustained virological response(End of study, on average 2.5 years after initiation)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Joost Drenth

Professor, MD, PhD

Radboud University Medical Center

研究点 (1)

Loading locations...

相似试验